Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,006 | -42,581 | -20,030 | -60,461 | -43,492 |
| Depreciation Amortization | 224 | 145 | 67 | 255 | 201 |
| Accounts payable and accrued liabilities | -202 | 1,536 | 932 | -654 | 1,455 |
| Other Working Capital | 16,433 | 4,169 | 379 | 3,940 | 4,997 |
| Other Operating Activity | 5,477 | 1,126 | 241 | 5,830 | 2,637 |
| Operating Cash Flow | $-37,075 | $-35,605 | $-18,412 | $-51,091 | $-34,202 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,039 | 35,036 | 4,039 | -29,797 | 5,000 |
| PPE Investments | -85 | -67 | -14 | -57 | -26 |
| Purchase Sale Intangibles | -215 | -192 | -189 | -187 | -6 |
| Other Investing Activity | -215 | -192 | -189 | -187 | -6 |
| Investing Cash Flow | $34,739 | $34,777 | $3,836 | $-30,041 | $4,968 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 47,434 | 244 | 83 | 64,253 | 30,653 |
| Other Financing Activity | -129 | -59 | -68 | 22,287 | 0 |
| Financing Cash Flow | $47,305 | $185 | $16 | $86,539 | $30,653 |
| Beginning Cash Position | 41,897 | 41,897 | 41,897 | 36,490 | 36,490 |
| End Cash Position | 86,866 | 41,254 | 27,337 | 41,897 | 37,908 |
| Net Cash Flow | $44,969 | $-643 | $-14,560 | $5,408 | $1,418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,075 | -35,605 | -18,412 | -51,091 | -34,202 |
| Capital Expenditure | -85 | -67 | -14 | -57 | -26 |
| Free Cash Flow | -37,160 | -35,672 | -18,426 | -51,148 | -34,228 |